DCW Ltd Reports 23% Revenue Growth, Profit Declines in Q2

Revenue: Rs 6,629 Mn (+22.9% YoY); PAT: Rs 104 Mn (-24.6% YoY).

Reader Takeaway: Strong revenue growth driven by chemical segments, but margin contraction due to freight costs hurts bottom line.

What just happened

DCW Ltd announced its financial results for Q2-FY27, showing a significant top-line expansion alongside a sharp decline in profitability. While revenue from operations reached Rs 6,629 million, the company's EBITDA dropped 18.1% year-on-year to Rs 475 million. This resulted in a margin contraction of 359 basis points to 7.17%.

Why this matters

The divergence between revenue and profit highlights current sector-specific headwinds. The Specialty Chemicals division, usually a profit driver, faced a 41.5% sequential decline in EBITDA. This was primarily driven by narrowing PVC-CPVC price spreads and rising ocean freight costs, which have impacted export profitability, particularly in North American markets.

Operational Highlights

There is a silver lining in the Basic Chemicals segment, which turned profitable in Q2-FY27 with an EBITDA of Rs 128 million. This turnaround was supported by normalized VCM-PVC spreads and higher sales volumes. The company is also moving forward with capacity expansions for its Synthetic Iron Oxide Pigment (SIOP) business, planning an investment of Rs 250 crore over the next 2-3 years across two phases.

Risks to watch

Investors should closely track the volatility of PVC-CPVC spreads, as this remains the primary influence on specialty chemicals' margins. Furthermore, the sustainability of the recent profitability in Basic Chemicals is not guaranteed, given the inherent volatility of commodity markets. Elevated global freight costs continue to act as a drag on export-heavy operations.

What to track next

The execution of the SIOP capacity expansion, targeted for completion in Q4-FY28, remains a key long-term indicator of growth. In the short term, management's ability to navigate high freight costs and stabilize margins in the Specialty Chemicals segment will be the primary focus for shareholders.